Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

NCT05897138 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

NCT01171482 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

NCT03586050 ·Status: COMPLETED ·Phase: NA

Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma

NCT02425605 ·Status: COMPLETED ·Phase: PHASE2

Proton Beam Therapy for Unresectable Liver Metastasis

NCT04456621 ·Status: COMPLETED ·Phase: NA

Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma

NCT02725073 ·Status: UNKNOWN ·Phase: PHASE2

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

NCT06648057 ·Status: RECRUITING

Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC

NCT04611165 ·Status: COMPLETED ·Phase: PHASE2

Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

NCT07047586 ·Status: RECRUITING ·Phase: PHASE2

Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.

NCT03140332 ·Status: COMPLETED ·Phase: NA

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

NCT05935579 ·Status: RECRUITING ·Phase: PHASE2

Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma

NCT06086002 ·Status: COMPLETED ·Phase: NA

A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

NCT05225207 ·Status: COMPLETED

First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment

NCT07297654 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT00105443 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC

NCT04124991 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC

NCT06519721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

NCT07282184 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy

NCT04161911 ·Status: COMPLETED

A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT00492752 ·Status: COMPLETED ·Phase: PHASE3

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

NCT01182272 ·Status: UNKNOWN ·Phase: PHASE2

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

NCT01932385 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.

NCT00444782 ·Status: COMPLETED ·Phase: PHASE2

Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

NCT02571946 ·Status: COMPLETED ·Phase: NA

Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma

NCT06034977 ·Status: RECRUITING ·Phase: PHASE2